PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+34.3%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.64B
AUM Growth
+$1.64B
(+35%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
38.22%
Holding
89
New
20
Increased
15
Reduced
21
Closed
18
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$75M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$63.5M |
| 3 |
Labcorp
LH
|
$51.5M |
| 4 |
Hologic
HOLX
|
$35M |
| 5 |
AstraZeneca
AZN
|
$33.6M |
Top Sells
| 1 |
Pfizer
PFE
|
$38.5M |
| 2 |
Becton Dickinson
BDX
|
$34.7M |
| 3 |
Cigna
CI
|
$34.5M |
| 4 |
Elevance Health
ELV
|
$32.6M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$30.7M |
Sector Composition
| 1 | Healthcare | 78.58% |
| 2 | Technology | 5.03% |
| 3 | Consumer Discretionary | 1.56% |
| 4 | Industrials | 0.73% |
| 5 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Shopify
SHOP
$184B
| $8.97M | 0.47% | 9,454 | – | – |
|
|
IGMS
52
DELISTED
IGM Biosciences
IGMS
| $8.47M | 0.44% | 115,988 -47,117 | -29% | -$3.44M |
|
53
Visa
V
$683B
| $8.4M | 0.44% | +43,468 | New | +$8.4M |
|
54
Standard BioTools
LAB
$481M
| $7.72M | 0.4% | 1,924,072 -749,018 | -28% | -$3M |
|
55
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $7.35M | 0.38% | 411,727 -62,328 | -13% | -$1.11M |
|
|
TRIL
56
DELISTED
Trillium Therapeutics Inc.
TRIL
| $6.92M | 0.36% | +855,270 | New | +$6.92M |
|
|
ZEN
57
DELISTED
ZENDESK INC
ZEN
| $5.94M | 0.31% | +67,034 | New | +$5.94M |
|
58
NextEra Energy, Inc.
NEE
$148B
| $4.94M | 0.26% | 20,570 +7,250 | +54% | +$1.74M |
|
59
Immunovant
IMVT
$2.56B
| $1.64M | 0.08% | +67,163 | New | +$1.64M |
|
|
ALNA
60
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $449K | 0.02% | 284,285 | – | – |
|
61
Alibaba
BABA
$322B
| – | – | -70,083 | Closed | -$13.6M |
|
62
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – | -81,804 | Closed | -$8.9M |
|
|
63
Becton Dickinson
BDX
$55.3B
| – | – | -151,150 | Closed | -$34.7M |
|
64
Biogen
BIIB
$19.4B
| – | – | -81,013 | Closed | -$25.6M |
|
|
65
Cigna
CI
$80.3B
| – | – | -194,690 | Closed | -$34.5M |
|
66
Centene
CNC
$14.3B
| – | – | -307,441 | Closed | -$18.3M |
|
67
Cencora
COR
$56.5B
| – | – | -338,732 | Closed | -$30M |
|
68
iShares China Large-Cap ETF
FXI
$6.65B
| – | – | 0 | – | – |
|
69
Insmed
INSM
$28.8B
| – | – | -228,781 | Closed | -$3.67M |
|
70
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
71
Pacira BioSciences
PCRX
$1.2B
| – | – | 0 | – | – |
|
|
72
Pfizer
PFE
$141B
| – | – | -1,180,658 | Closed | -$38.5M |
|
73
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
|
SAGE
74
DELISTED
Sage Therapeutics
SAGE
| – | – | -436,477 | Closed | -$12.5M |
|
75
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|